INTRODUCTION
============

Splenic injury is common affecting up to 32% of patients with blunt abdominal trauma.[@b1-12-3-83]--[@b5-12-3-83] Laparotomy is accepted as the recommended management strategy for blunt splenic injury in hemodynamically unstable patients.[@b2-12-3-83]--[@b14-12-3-83] In contrast, the efficacy of nonoperative management in hemodynamically stable patients may consist of observation (with or without angiography) or angiography with proximal or selective splenic embolization.[@b1-12-3-83]--[@b5-12-3-83] The failure rate of observation alone is high for patients with contrast blush on computed tomography (CT), grade IV injuries (lacerations involving segmental or hilar vessels producing major devascularization greater than 25% of the spleen) or grade V injuries (completely shattered spleens or spleens with hilar vascular injury which devascularizes the spleen),[@b15-12-3-83] higher injury severity score (ISS), decreasing hemoglobin, and presence of vascular injury or large volume hemoperitoneum.[@b2-12-3-83]--[@b6-12-3-83],[@b8-12-3-83]--[@b10-12-3-83],[@b12-12-3-83],[@b14-12-3-83] Age as a risk factor for failure of nonoperative management has been evaluated with some evidence showing increased failure rates in older age groups,[@b3-12-3-83],[@b16-12-3-83]--[@b18-12-3-83] but other studies have shown no such association.[@b19-12-3-83]--[@b26-12-3-83]

Angiography with the option of performing splenic artery embolization has emerged as a viable option to decrease the rate of nonoperative management failure.[@b2-12-3-83]--[@b4-12-3-83],[@b6-12-3-83]--[@b14-12-3-83] Embolization is completed either by occluding the main splenic artery, referred to as proximal embolization, or by selectively targeting splenic artery branches with visualized injuries on angiography, referred to as distal embolization. Proposed benefits to proximal embolization include speed and ease of procedure, lower cost, and fewer splenic abscesses and infarctions.[@b27-12-3-83]--[@b29-12-3-83] A significant disadvantage includes rendering the splenic artery inaccessible for future angiographic interventions.[@b5-12-3-83] It is controversial if either site is associated with a lower failure rate. The literature is clear that splenic artery embolization is associated with preserved immune function compared to splenectomy.[@b30-12-3-83]--[@b33-12-3-83] Studies evaluating the effects of proximal versus distal splenic artery embolization on immune function have not shown a difference between these methodologies, although these studies have included only small data sets and may not have sufficient power to detect any variability.[@b30-12-3-83]--[@b32-12-3-83]

The aim of this study was to evaluate modes of treatment of blunt splenic injury based on patient factors, physiology, splenic injury severity, and associated injuries based on radiographic findings. A secondary aim was to assess if there were any differences in failure rate and complications between those treated with proximal versus distal splenic artery embolization.

METHODS
=======

A retrospective review was conducted of all patients 18 years of age or older with a splenic injury following blunt trauma. A total of 405 patients were identified initially through a search of our trauma registry, of which 62 were excluded. The remaining 343 patients were the focus of this investigation. All patients were evaluated at an American College of Surgeons-verified level I Trauma Center from January 1, 2008 to February 1, 2017. Data collection included demographics (age, gender, and race), imaging results at admission, injury characteristics, treatment modality (observation, embolization, and surgery), complications, and hospital outcomes (mechanical ventilation, days on mechanical ventilation, intensive care unit \[ICU\] admission and length of stay, hospital length of stay, and in-hospital mortality). The amount of hemoperitoneum was quantified on CT into mild, moderate, and severe. Hemoperitoneum was defined as mild if blood was confined to the peri-splenic area, moderate if blood was found throughout the left abdomen, and severe if it extended to the right hemi-abdomen. Data regarding embolization was identified by reviewing procedure reports and imaging.

For comparisons, patients were categorized based on treatment modality: observation alone, embolization, or operative intervention. Operative intervention included splenectomy and splenorrhaphy. Patients who underwent angiography without embolization were included in the observation group. Failure was defined as additional procedures (embolization, splenectomy, or splenorrhaphy) occurring in a patient who initially had been managed non-operatively.

Comparisons of categorical data were conducted using χ^2^ analysis with Fisher's exact correction for comparisons with expected counts less than five in any cell. Comparisons of continuous data were done using one-way analysis of variance for normally distributed variables and a non-parametric test of medians for variables that did not meet the assumption of normality. When a test of medians could not be accomplished, a Kruskal-Wallis test was used to assess differences in distributions between groups on the variable of interest. All statistical tests were two-sided and analyses were considered significant when the resultant p value was ≤ 0.05.

Pairwise comparisons were conducted when a significant p value indicated differences between the three study groups ([Tables 2](#t2-12-3-83){ref-type="table"}[](#t3-12-3-83){ref-type="table"}[](#t4-12-3-83){ref-type="table"}[](#t5-12-3-83){ref-type="table"} -- [6](#t6-12-3-83){ref-type="table"}). Paired values within a row in each table with different superscripts were different with a p \< 0.05. Bonferroni or Games-Howell corrections were used to correct for multiple comparisons for cases in which homogeneity of variance could and could not be assumed, respectively. For Bonferroni corrections, the resultant p value was multiplied by the number of comparisons to calculate an adjusted p value. All analyses, except where noted, were conducted using SPSS release 24.0 (IBM Corp., Somers, New York). This study was approved for implementation by the institutional review board of Via Christi Hospitals Wichita Inc.

RESULTS
=======

Patient Demographics, Injury Severity, Initial Vital Signs, and Injury Details
------------------------------------------------------------------------------

Patient demographics were similar between the three groups with no differences in age, gender, or race between treatment modalities ([Table 1](#t1-12-3-83){ref-type="table"}). Admission parameters are listed in [Table 2](#t2-12-3-83){ref-type="table"}. Patients that were treated operatively had a higher overall ISS than those managed with either observation or embolization (31 vs 17 and 20, respectively, p \< 0.001). Those treated by observation alone had a lower splenic injury grade (2) than those treated with embolization or surgically (3 and 3, respectively, p \< 0.001), the latter treatment modalities having similar splenic injury grades. There was no significant difference in overall ISS in those treated with observation alone or with embolization. More patients in the operative group were described as hemodynamically unstable on admission with lower systolic and diastolic blood pressure, and higher heart rate than were seen in the observation and embolization groups. More patients undergoing operative intervention required blood transfusions than the embolization or observation groups. Concomitant injuries such as traumatic brain injury, spinal injury, pneumothorax, hemothorax, rib fractures, liver injury, renal injury, and extremity fractures were varied, but overall were common, and were generally more prevalent in the operative group ([Table 3](#t3-12-3-83){ref-type="table"}).

Radiographic Findings
---------------------

Radiographic parameters were evaluated as a possible modality to predict appropriate management ([Table 4](#t4-12-3-83){ref-type="table"}). Contrast blush on CT was seen significantly more often in the embolization and operative groups compared to the observation group, yet blush was seen in less than half of each group. Mild hemoperitoneum was seen relatively frequently in all three groups, with severe hemoperitoneum occurring more commonly in the operative group than the non-operative groups.

Treatment Failures
------------------

There were no treatment failures in the embolization group. In the observation group, there were 19 treatment failures for an overall failure rate of 11.2%. Splenectomy and splenorrhaphy were each performed once, while the remaining 17 failures underwent embolization. Of note, the patient that underwent splenorrhaphy had undergone exploratory laparotomy for another reason, and splenorrhaphy was performed incidentally due to that procedure. Each of these patients showed severe hemoperitoneum on CT imaging.

Complications and Hospital Outcomes
-----------------------------------

Complications are listed in [Table 5](#t5-12-3-83){ref-type="table"}. The fewest complications were seen in the embolization group. The incidence of wound infections (11.5% vs 1.3% vs 0%, p \< 0.001), pneumonia (12.3% vs 7.9% vs 1.3%, p = 0.033), and other complications, such as urinary tract infection, deep vein thrombosis, and pressure sores (46.6% vs 17.6% vs 5.3%, p \< 0.001) were significantly higher in the operative group than in the observation and embolization groups, respectively. Operative patients also had a greater need for mechanical ventilation (75.0% vs 24.9% vs 11.5%, p \< 0.001), although total ventilator days were not significantly different than the observation group or the embolization group ([Table 6](#t6-12-3-83){ref-type="table"}). Intensive care unit admission was common among all three groups, with operative patients requiring a longer length of stay in both the ICU setting and hospital. Operative patients also succumbed to their injuries and experienced in-hospital mortality more frequently than their counterparts managed non-operatively (26.3% vs 4.1% and 2.6%, p \< 0.001).

Proximal vs Distal Embolization Outcomes
----------------------------------------

This study gathered data comparing proximal and distal splenic artery embolization. There were no differences in baseline admission vital signs, grade of splenic injury, or concomitant injuries between these groups (data not shown). There were significantly more patients with moderate hemoperitoneum that underwent proximal embolization (41.3% vs 11.8%, p = 0.045), although this difference was no longer seen in patients with severe hemoperitoneum (2.2% vs 11.8%, p = 0.213). Importantly, there was no difference in complication rates or hospital factors (ICU admission and length of stay, need for mechanical ventilation, and hospital length of stay) between these groups (data not shown).

DISCUSSION
==========

The primary goal of this study was to compare treatment modalities for blunt splenic injury based on patient factors, physiology, splenic injury severity, and associated injuries based on radiographic findings. Our findings demonstrated that all three management strategies can be appropriate in the right clinical setting. Our treatment failure rates for observation (11.2% compared to 10% -- 18%)[@b5-12-3-83],[@b9-12-3-83],[@b11-12-3-83],[@b34-12-3-83] and embolization (0% compared to 0% -- 8%)[@b9-12-3-83],[@b11-12-3-83] are in line with the low end of other published data.

Prior studies have touted lower systolic blood pressure, higher ISS, lower pH, and greater need for pRBC transfusions as predictors for operative intervention.[@b4-12-3-83],[@b35-12-3-83] This study supported these findings as seen in [Table 2](#t2-12-3-83){ref-type="table"}, although pH was not assessed. Increasing age, often using cutoff values of greater than 55 or greater than 65 years of age, has been described as both an indication for operative management and a predictor for failure of non-operative management,[@b3-12-3-83],[@b16-12-3-83]--[@b18-12-3-83] while other studies refute these conclusions.[@b19-12-3-83]--[@b26-12-3-83] In this study, age was not different amongst the three groups, and the low failure rate of non-operative management suggested that age is not a determining factor for management decisions.

Radiographic parameters did not show any clear patterns amongst the three groups. Mild hemoperitoneum was the most common finding regardless of selected treatment modality, with moderate hemoperitoneum most frequent in the embolization group and severe in the operative group. However, embolization also was successful in treating patients with severe hemoperitoneum. In accordance, Wahl et al.[@b23-12-3-83] found that contrast extravasation or degree of hemoperitoneum visualized on CT scan did not accurately predict the need for intervention, be it operation or embolization.

Complications were observed most frequently in the operative group, including wound infection, pneumonia, and other complications (e.g., deep vein thrombosis, urinary tract infection), as expected with emergent major abdominal surgery. These complications could be due either to the concomitant injuries and higher overall Injury Severity Score or related to the surgery itself. The need for advanced interventions was also highest in the operative group, as well as longer length of ICU and hospital stay. These results likely would be expected as this group was more severely injured as evidenced by a higher ISS, lower Glasgow Coma Scale score, and higher incidence of hemodynamic instability upon admission. Prior data from this institution demonstrated lower complication rates with splenic artery embolization compared to operative intervention.[@b6-12-3-83] Interestingly, the embolization group displayed fewer complications than the patients that were observed, as well as a lower need for mechanical ventilation, contrary to previous data.[@b36-12-3-83] The reason for this is unclear, although it may be due to an unwillingness of staff to allow borderline patients to leave the close observation and direct control of the ICU situation. There was no difference in complication rate between proximal and distal embolization groups. Mortality was highest in the operative group and low and relatively equal in the non-operative groups.

The secondary aim of this study was to evaluate differences between proximal and distal splenic artery embolization. Our data showed no differences in baseline admission characteristics between these groups. Evaluation of pre-procedural imaging indicated that there were significantly more patients with moderate hemoperitoneum undergoing proximal splenic artery embolization; however, this difference was not seen in patients with severe hemoperitoneum. There was a technical success rate of 100%, with embolization completed in all instances and no need for repeat embolization or operative intervention. This compared to a success rate of 91% -- 95% in other studies,[@b37-12-3-83],[@b38-12-3-83] with some data showing a trend toward a greater rate of re-bleeding in distal embolizations.[@b38-12-3-83] Location of embolization and material used were left to the interventional radiologist's discretion, so the selection in each circumstance may be a matter of preference or other unknown factors. Previous literature ascribed a greater rate of splenic abscesses and infarctions to distal splenic artery embolization, but this was not captured in this study as we included only in-hospital complications.

This study had several limitations, first of which were the limitations inherent with any study of retrospective design and the subsequent availability of data being limited to that which were present in the patient's medical record. Small sample size and data from a single institution limited the generalizability of these findings. The relatively small number of treatment failures prevented robust multivariate analyses from being performed to elucidate factors that are predictive of treatment failures while adjusting for differences between groups. Only data from the index hospital admission were included, which could have resulted in the omission of some complications that presented after discharge.

Prospective studies are needed to determine the optimal treatment of blunt splenic injury based on measurable data such as admission criteria or imaging findings. Taken as a whole, the low failure rates of observation and embolization with comparatively low complication rates suggested that avoiding the physiologic insult of surgery may provide substantial benefit. The wide variation in degree of hemoperitoneum treated with operative intervention may indicate over-utilization of surgical intervention in mild or moderate hemoperitoneum. Additionally, fewer complications in the embolization group relative to the observation group may indicate that a proactive treatment such as embolization may provide benefit over a period of observation, particularly in patients with severe hemoperitoneum; however, complications measured were biased towards those expected with operative intervention rather than embolization. Prospective studies should be completed to further clarify these factors. Cost studies also would help with economic decision-making. Development of a predictive model hopefully would account for fewer unnecessary operations, avoiding the risk and complications associated with surgery, and improve the success rate of embolization and non-operative management.

CONCLUSION
==========

In conclusion, this study demonstrated low rates of treatment failure in the observation and embolization groups, consistent with the lower end of other published data. The rate of complications was lowest amongst the embolization groups, with no difference between the proximal and distal splenic artery embolization groups, making it an attractive treatment option in appropriately selected patients.

###### 

Comparison of demographics for patients undergoing observation, embolization, or operative management of splenic trauma.

  Parameter                                   Treatment Group   p value                     
  ------------------------------------------- ----------------- ------------- ------------- -------
  Number of observations                      169 (49.3)        78 (22.7)     96 (28.0)     \-\--
  Age (years; Mean ± SD)                      41.0 ± 18.5       39.6 ± 17.1   42.0 ± 17.8   0.676
  Male                                        117 (69.2)        60 (62.5)     70 (72.9)     0.264
  Race                                                                                      0.956
   White                                      155 (91.7)        71 (91.0)     90 (93.8)     
   Black                                      3 (1.8)           2 (2.6)       2 (2.1)       
   Asian                                      1 (0.6)           0 (0.0)       1 (1.0)       
  Native Hawaiian or other Pacific Islander   1 (0.6)           0 (0.0)       0 (0.0)       
  Other                                       9 (5.3)           5 (6.4)       3 (3.1)       

###### 

Comparison of injury severity for patients undergoing observation, embolization, or operative management of splenic trauma.

  Parameter                                                                Treatment Group[\*](#tfn1-12-3-83){ref-type="table-fn"}   p value                                                                                                     
  ------------------------------------------------------------------------ --------------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------
  Number of observations                                                   169 (49.3)                                                78 (22.7)                                             96 (28.0)                                             \-\--
  Injury severity score                                                    17 (9,27)[a](#tfn3-12-3-83){ref-type="table-fn"}          20 (10,27)[a](#tfn3-12-3-83){ref-type="table-fn"}     31 (22,41)[b](#tfn3-12-3-83){ref-type="table-fn"}     \< 0.001
  Glasgow Coma Scale score                                                 15 (14,15)[a](#tfn3-12-3-83){ref-type="table-fn"}         15 (15,15)[a](#tfn3-12-3-83){ref-type="table-fn"}     14 (3,15)[b](#tfn3-12-3-83){ref-type="table-fn"}      \< 0.001
  Systolic blood pressure (mmHg)                                           127.7 ± 29.3[a](#tfn3-12-3-83){ref-type="table-fn"}       122.5 ± 20.3[a](#tfn3-12-3-83){ref-type="table-fn"}   103.5 ± 27.4[b](#tfn3-12-3-83){ref-type="table-fn"}   \< 0.001
  Diastolic blood pressure (mmHg)[†](#tfn2-12-3-83){ref-type="table-fn"}   81.4 ± 22.9[a](#tfn3-12-3-83){ref-type="table-fn"}        81.8 ± 17.9[a](#tfn3-12-3-83){ref-type="table-fn"}    68.4 ± 22.8[b](#tfn3-12-3-83){ref-type="table-fn"}    \< 0.001
  Heart rate (bpm)                                                         95.1 ± 22.5[a](#tfn3-12-3-83){ref-type="table-fn"}        100.6 ± 21.7[a](#tfn3-12-3-83){ref-type="table-fn"}   111.5 ± 28.5[b](#tfn3-12-3-83){ref-type="table-fn"}   \< 0.001
  Hemoglobin (g/dL)[†](#tfn2-12-3-83){ref-type="table-fn"}                 13.4 ± 3.4[a](#tfn3-12-3-83){ref-type="table-fn"}         12.2 ± 2.3[b](#tfn3-12-3-83){ref-type="table-fn"}     11.5 ± 3.4[b](#tfn3-12-3-83){ref-type="table-fn"}     \< 0.001
  Hemodynamically stable[†](#tfn2-12-3-83){ref-type="table-fn"}            141 (89.2)[a](#tfn3-12-3-83){ref-type="table-fn"}         75 (96.2)[a](#tfn3-12-3-83){ref-type="table-fn"}      18 (18.9)[b](#tfn3-12-3-83){ref-type="table-fn"}      \< 0.001
  Transfusion required                                                     45 (26.6)[a](#tfn3-12-3-83){ref-type="table-fn"}          19 (24.4)[a](#tfn3-12-3-83){ref-type="table-fn"}      83 (86.5)[b](#tfn3-12-3-83){ref-type="table-fn"}      \< 0.001

Data are presented as Number (%), Median (interquartile range), or Mean ± SD.

Missing values are present in the dataset.

Values within a row with different superscript letters are significant at the 0.05 level.

###### 

Injury details for patients undergoing non-operative, operative, and embolization management of splenic trauma.

  Parameter                                                       Treatment Group[\*](#tfn4-12-3-83){ref-type="table-fn"}                                    p value                                                                                               
  --------------------------------------------------------------- ------------------------------------------------------------------------------------------ -------------------------------------------------- -------------------------------------------------- ----------
  Number of observations                                          169 (49.3)                                                                                 78 (22.7)                                          96 (28.0)                                          \-\--
  Traumatic brain injury                                          61 (36.1)[a](#tfn6-12-3-83){ref-type="table-fn"},[b](#tfn6-12-3-83){ref-type="table-fn"}   23 (29.5)[b](#tfn6-12-3-83){ref-type="table-fn"}   48 (50.0)[a](#tfn6-12-3-83){ref-type="table-fn"}   0.015
  Spine injury                                                    47 (27.8)[a](#tfn6-12-3-83){ref-type="table-fn"},[b](#tfn6-12-3-83){ref-type="table-fn"}   13 (16.7)[b](#tfn6-12-3-83){ref-type="table-fn"}   36 (37.5)[a](#tfn6-12-3-83){ref-type="table-fn"}   0.010
  Pneumothorax                                                    47 (27.8)[a](#tfn6-12-3-83){ref-type="table-fn"},[b](#tfn6-12-3-83){ref-type="table-fn"}   17 (22.1)[b](#tfn6-12-3-83){ref-type="table-fn"}   39 (40.6)[a](#tfn6-12-3-83){ref-type="table-fn"}   0.018
  Hemothorax                                                      26 (15.4)                                                                                  5 (6.4)                                            18 (18.8)                                          0.058
  Rib fractures                                                   85 (50.3)                                                                                  33 (42.3)                                          58 (60.4)                                          0.055
  Grade of spleen injury[†](#tfn5-12-3-83){ref-type="table-fn"}   2 (1,3)[a](#tfn6-12-3-83){ref-type="table-fn"}                                             3 (3,4)[b](#tfn6-12-3-83){ref-type="table-fn"}     3 (2,4)[b](#tfn6-12-3-83){ref-type="table-fn"}     \< 0.001
  Liver injury                                                    27 (16.0)[a](#tfn6-12-3-83){ref-type="table-fn"},[b](#tfn6-12-3-83){ref-type="table-fn"}   4 (5.1)[b](#tfn6-12-3-83){ref-type="table-fn"}     26 (27.1)[a](#tfn6-12-3-83){ref-type="table-fn"}   0.001
   Grade of liver injury[†](#tfn5-12-3-83){ref-type="table-fn"}   2 (1,3)                                                                                    2 (1,n/a)                                          3 (1,4)                                            0.323
  Kidney injury                                                   23 (13.6)[a](#tfn6-12-3-83){ref-type="table-fn"},[b](#tfn6-12-3-83){ref-type="table-fn"}   3 (3.8)[b](#tfn6-12-3-83){ref-type="table-fn"}     20 (20.8)[a](#tfn6-12-3-83){ref-type="table-fn"}   \< 0.005
  Bladder injury                                                  2 (1.2)                                                                                    2 (2.6)                                            1 (1.0)                                            0.715
  Extremity injury                                                61 (35.7)[a](#tfn6-12-3-83){ref-type="table-fn"}                                           27 (34.6)[a](#tfn6-12-3-83){ref-type="table-fn"}   56 (58.3)[b](#tfn6-12-3-83){ref-type="table-fn"}   0.001
  Vascular injury[†](#tfn5-12-3-83){ref-type="table-fn"}          14 (8.8)                                                                                   4 (5.3)                                            3 (3.2)                                            0.204

Data are presented as Number (%) or Median (interquartile range).

Missing values are present in the dataset.

Values within a row with different superscript letters are significant at the 0.05 level.

###### 

Comparison of radiology findings for patients undergoing observation, embolization, or operative management of splenic trauma.

  Parameter                                                           Treatment Group                                    p value                                                                                                                                       
  ------------------------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------------------ ----------
  Number of observations                                              169 (49.3)                                         78 (22.7)                                          96 (28.0)                                                                                  \-\--
  Contrast blush[\*](#tfn7-12-3-83){ref-type="table-fn"}              13 (9.0)[a](#tfn8-12-3-83){ref-type="table-fn"}    30 (46.9)[b](#tfn8-12-3-83){ref-type="table-fn"}   28 (47.5)[b](#tfn8-12-3-83){ref-type="table-fn"}                                           \< 0.001
  Hemoperitoneum (mild)[\*](#tfn7-12-3-83){ref-type="table-fn"}       58 (40.3)                                          30 (46.9)                                          22 (37.3)                                                                                  0.529
  Hemoperitoneum (moderate)[\*](#tfn7-12-3-83){ref-type="table-fn"}   20 (13.9)[a](#tfn8-12-3-83){ref-type="table-fn"}   21 (31.8)[b](#tfn8-12-3-83){ref-type="table-fn"}   14 (23.7)[a](#tfn8-12-3-83){ref-type="table-fn"},[b](#tfn8-12-3-83){ref-type="table-fn"}   0.006
  Hemoperitoneum (severe)[\*](#tfn7-12-3-83){ref-type="table-fn"}     3 (2.1)[a](#tfn8-12-3-83){ref-type="table-fn"}     3 (4.7)[a](#tfn8-12-3-83){ref-type="table-fn"}     16 (27.1)[b](#tfn8-12-3-83){ref-type="table-fn"}                                           \< 0.001

Missing values are present in the dataset.

Values within a row with different superscript letters are significant at the 0.05 level.

###### 

Complications for patients undergoing observation, embolization, or operative management of splenic trauma.

  Parameter                                                     Treatment Group                                                                             p value                                                                                               
  ------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------- --------------------------------------------------- ----------
  Number of observations                                        169 (49.3)                                                                                  78 (22.7)                                         96 (28.0)                                           \-\--
  Complications (any)[\*](#tfn9-12-3-83){ref-type="table-fn"}   31 (18.8)[a](#tfn10-12-3-83){ref-type="table-fn"}                                           4 (5.3)[b](#tfn10-12-3-83){ref-type="table-fn"}   37 (50.7)[c](#tfn10-12-3-83){ref-type="table-fn"}   \< 0.001
  Pulmonary embolism[\*](#tfn9-12-3-83){ref-type="table-fn"}    1 (0.6)                                                                                     0 (0.0)                                           2 (2.7)                                             0.191
  Pneumonia[\*](#tfn9-12-3-83){ref-type="table-fn"}             13 (7.9)[a](#tfn10-12-3-83){ref-type="table-fn"},[b](#tfn10-12-3-83){ref-type="table-fn"}   1 (1.3)[b](#tfn10-12-3-83){ref-type="table-fn"}   9 (12.3)[a](#tfn10-12-3-83){ref-type="table-fn"}    0.033
  Wound infection[\*](#tfn9-12-3-83){ref-type="table-fn"}       2 (1.3)[a](#tfn10-12-3-83){ref-type="table-fn"}                                             0 (0.0)[a](#tfn10-12-3-83){ref-type="table-fn"}   9 (11.5)[b](#tfn10-12-3-83){ref-type="table-fn"}    \< 0.001
  Dehiscence[\*](#tfn9-12-3-83){ref-type="table-fn"}            2 (1.2)                                                                                     0 (0.0)                                           0 (0.0)                                             \> 0.999
  Other complications[\*](#tfn9-12-3-83){ref-type="table-fn"}   29 (17.6)[a](#tfn10-12-3-83){ref-type="table-fn"}                                           4 (5.3)[b](#tfn10-12-3-83){ref-type="table-fn"}   34 (46.6)[c](#tfn10-12-3-83){ref-type="table-fn"}   \< 0.001

Missing values are present in the dataset.

Values within a row with different superscript letters are significant at the 0.05 level.

###### 

Hospital outcomes for patients undergoing non-operative, operative, and embolization management of splenic trauma.

  Parameter                                                                                   Treatment Group[\*](#tfn11-12-3-83){ref-type="table-fn"}   p value                                                                                                  
  ------------------------------------------------------------------------------------------- ---------------------------------------------------------- -------------------------------------------------- ----------------------------------------------------- ----------
  Number of observations                                                                      169 (49.3)                                                 78 (22.7)                                          96 (28.0)                                             \-\--
  Mechanical ventilation                                                                      42 (24.9)[a](#tfn14-12-3-83){ref-type="table-fn"}          9 (11.5)[b](#tfn14-12-3-83){ref-type="table-fn"}   72 (75.0)[c](#tfn14-12-3-83){ref-type="table-fn"}     \< 0.001
   Ventilator days[†](#tfn12-12-3-83){ref-type="table-fn"}                                    7 (2,16.3)[a](#tfn14-12-3-83){ref-type="table-fn"}         2 (2,9)[a](#tfn14-12-3-83){ref-type="table-fn"}    4 (1.3,15)[a](#tfn14-12-3-83){ref-type="table-fn"}    0.042
  ICU admission                                                                               141 (83.4)                                                 73 (93.6)                                          84 (87.5)                                             0.087
   ICU days[†](#tfn12-12-3-83){ref-type="table-fn"}[‡](#tfn13-12-3-83){ref-type="table-fn"}   2 (1,6)[a](#tfn14-12-3-83){ref-type="table-fn"}            2 (1,3)[a](#tfn14-12-3-83){ref-type="table-fn"}    5.5 (2,18)[b](#tfn14-12-3-83){ref-type="table-fn"}    \< 0.001
  Hospital length of stay                                                                     5 (3,10)[a](#tfn14-12-3-83){ref-type="table-fn"}           4 (3,7)[a](#tfn14-12-3-83){ref-type="table-fn"}    10 (3,21.8)[b](#tfn14-12-3-83){ref-type="table-fn"}   0.001
  Mortality                                                                                   7 (4.1)[a](#tfn14-12-3-83){ref-type="table-fn"}            2 (2.6)[a](#tfn14-12-3-83){ref-type="table-fn"}    25 (26.3)[b](#tfn14-12-3-83){ref-type="table-fn"}     \<0.001

Data are presented as Number (%) or Median (interquartile range).

Only individuals with non-zero days included in analysis.

Missing values are present in the dataset.

Values within a row with different superscript letters are significant at the 0.05 level.
